Table II.
Pathway | Gene Symbol | dbSNP ID | Chromosome | Genotype | Maternally-derived effect | Paternally-derived Relative Risk (95% CI) | P-value for paternal vs. maternal effect |
---|---|---|---|---|---|---|---|
Transsulfuration | GLRX | rs17085159 | 5 | A/G | referent | 0.23 (0.12, 0.44) | 2.66×10-6 |
Transsulfuration | GSR | rs7818511 | 8 | A/G | referent | 0.31 (0.18, 0.53) | 9.94×10-6 |
Transsulfuration | GLRX | rs12109442 | 5 | T/A | referent | 0.27 (0.14, 0.50) | 2.06×10-5 |
Homocysteine | MTRR | rs1801394 | 5 | G/A | referent | 0.48 (0.33, 0.71) | 8.72×10-5 |
Transsulfuration | GSTA3 | rs614765 | 6 | G/C | referent | 0.41 (0.25, 0.67) | 2.70×10-4 |
Folate | MTHFD2 | rs6745054 | 2 | G/A | referent | 0.47 (0.31, 0.72) | 3.05×10-4 |
Transsulfuration | GCLC | rs13437395 | 6 | G/A | referent | 0.40 (0.24, 0.67) | 3.68×10-4 |
Transsulfuration | OGG1 | rs2072668 | 3 | G/C | referent | 0.47 (0.31, 0.73) | 3.95×10-4 |
Transsulfuration | MGMT | rs483959 | 10 | A/G | referent | 0.53 (0.36, 0.77) | 5.05×10-4 |
Homocysteine | DNMT3B | rs7360212 | 20 | C/A | referent | 0.22 (0.09, 0.53) | 5.23×10-4 |
Transsulfuration | GLRX | rs11953653 | 5 | A/G | referent | 1.78 (1.29, 2.45) | 5.98×10-4 |
Transsulfuration | MGMT | rs4751106 | 10 | A/C | referent | 0.55 (0.39, 0.79) | 6.93×10-4 |
Transsulfuration | GCLC | rs2277108 | 6 | A/G | referent | 0.43 (0.26, 0.71) | 6.96×10-4 |
Transsulfuration | SOD1 | rs16988427 | 21 | G/A | referent | 0.32 (0.16, 0.63) | 7.29×10-4 |
Transsulfuration | GSTP1 | rs7927381 | 11 | A/G | referent | 0.46 (0.28, 0.73) | 8.35×10-4 |
Transsulfuration | GCLC | rs606548 | 6 | A/G | referent | 0.42 (0.25, 0.72) | 1.14×10-3 |
Transsulfuration | GCLC | rs12524494 | 6 | G/A | referent | 0.41 (0.23, 0.71) | 1.29×10-3 |
Folate | RFC1 | rs2062228 | 4 | A/G | referent | 0.23 (0.09, 0.59) | 1.46×10-3 |
Transsulfuration | MGMT | rs544217 | 10 | A/G | referent | 0.58 (0.41, 0.82) | 1.50×10-3 |
Transsulfuration | GCLC | rs13437220 | 6 | C/G | referent | 0.45 (0.27, 0.74) | 1.55×10-3 |